Lv5
1270 积分 2022-06-08 加入
Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Suboptimal Initial Clinical Response and Weight Gain Recurrence After Bariatric Surgery: a Systematic Review and Meta-analysis
1天前
已完结
Dozens of new obesity drugs are coming: these are the ones to watch
3天前
已完结
What Does the Rise of GLP-1 Drugs Mean for Bariatric Surgery?
5天前
已完结
Safety and efficacy of glucagon-like peptide-1 (GLP-1) receptor agonists in patients with weight regain or insufficient weight loss after metabolic bariatric surgery: A systematic review and meta-analysis
16天前
已完结
Glucagon-Like Peptide-1 Receptor Agonists in Post-bariatric Surgery Patients: A Systematic Review and Meta-analysis
16天前
已完结
Effect of Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) on Weight Loss Following Bariatric Treatment
16天前
已完结
Adjuvant and Neo-Adjuvant Anti-Obesity Medications and Bariatric Surgery: A Scoping Review
23天前
已完结
Definition and diagnostic criteria of clinical obesity
23天前
已完结
Treatment of obesity: will incretin agonists make bariatric surgery a thing of the past?
24天前
已完结
Weight regain after bariatric surgery: A systematic review and meta-analysis of observational studies
1个月前
已关闭
皖公网安备34019202002308
